Literature DB >> 18460623

Characterization of fluoroquinolone resistance in Escherichia coli strains from ruminants.

Sonia Jurado1, José A Orden, Pilar Horcajo, Ricardo De La Fuente, José A Ruiz-Santa-Quiteria, Susana Martínez-Pulgarín, Gustavo Domínguez-Bernal.   

Abstract

Thirty-seven fluoroquinolone-resistant Escherichia coli strains from ruminants (according to Clinical and Laboratory Standards Institute guidelines) were screened by molecular methods for mutations in the quinolone resistance-determining region (QRDR) of the gyrA and parC genes and for the presence of the qnrA gene. One of the strains studied was an enterohemorrhagic E. coli (EHEC) strain potentially pathogenic for humans. Three E. coli strains resistant to enrofloxacin (minimal inhibitory concentration [MIC] = 2 microg/ml) but not to ciprofloxacin (MIC = 1 microg/ml) presented single mutations in the gyrA and parC genes, while 34 strains resistant to both fluoroquinolones presented double and single mutations in gyrA and parC, respectively (31 strains), or double mutations in gyrA and parC (3 strains). The EHEC strain presented a double amino acid substitution in the GyrA protein (Ser-83-->Leu and Asp-87-->Gly) and a double amino acid substitution in the ParC protein (Gly-78-->Cys and Ser-80-->Arg), one of which has not been previously described. The present study shows that most of the mutations in the QRDR of the gyrA and parC genes of fluoroquinolone-resistant E. coli strains from ruminants are the same as those seen in E. coli strains from other animal species and humans and that there are no differences in mutation patterns in the QRDR of E. coli strains from healthy ruminants and those with diarrhea. No strains carried qnrA, which indicates that this gene does not play an important role in the selection of fluoroquinolone-resistant E. coli strains from ruminants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460623     DOI: 10.1177/104063870802000314

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  6 in total

1.  Changing paradigm of antibiotic resistance amongst Escherichia coli isolates in Indian pediatric population.

Authors:  Taru Singh; Praveen Kumar Singh; Sajad Ahmad Dar; Shafiul Haque; Naseem Akhter; Shukla Das
Journal:  PLoS One       Date:  2019-04-17       Impact factor: 3.240

2.  Prevalence and molecular detection of fluoroquinolone-resistant genes (qnrA and qnrS) in Escherichia coli isolated from healthy broiler chickens.

Authors:  Shahin Mahmud; K H M Nazmul Hussain Nazir; Md Tanvir Rahman
Journal:  Vet World       Date:  2018-12-24

3.  Plasmid-mediated fluoroquinolone resistance associated with extra-intestinal Escherichia coli isolates from hospital samples.

Authors:  Shruthi S Shetty; Vijaya Kumar Deekshit; Kadeeja Jazeela; Rajeshwari Vittal; Anusha Rohit; Anirban Chakraborty; Indrani Karunasagar
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

4.  Isolation and detection of antibiotics resistance genes of Escherichia coli from broiler farms in Sukabumi, Indonesia.

Authors:  Aprilia Hardiati; Safika Safika; I Wayan Teguh Wibawan; Agustin Indrawati; Fachriyan Hasmi Pasaribu
Journal:  J Adv Vet Anim Res       Date:  2021-03-05

5.  Determination of the potency of hexyl-ciprofloxacin molecules that interact with gold nanoparticles in a reversible manner.

Authors:  Francisco Montero-Silva; Marcelo J Kogan; Iván Montenegro; Fanny Guzmán; Soledad Navarrete; Carolina Parra; Michael Seeger
Journal:  IET Nanobiotechnol       Date:  2019-05       Impact factor: 1.847

6.  Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.

Authors:  Angeliki Mavroidi; Vivi Miriagou; Apostolos Liakopoulos; Εva Tzelepi; Angelos Stefos; George N Dalekos; Efthymia Petinaki
Journal:  BMC Infect Dis       Date:  2012-12-23       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.